CHRETO ApS: Financial statements 2014
CVR: 33382170
CHRETO ApS (CVR 33382170) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,711 and a net result of DKK 4,711 compared with DKK 13,142 the year before. That is a decrease of 63.9% compared with the year before. Equity amounted to DKK 167,143. The solvency ratio was 9.9%.
- Gross Profit
- 4,711 kr.
- Profit/Loss
- 4,711 kr.
- Equity
- 167,143 kr.
- Total Assets
- 1,686,269 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 5 t. | 5 t. | 167 t. | - |
| 2013 | - | 13 t. | 13 t. | 162 t. | - |
Keep an eye on CHRETO ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of September 13, 2014, Torben Vedel Stahl Jørgensen has joined the board of directors of CHRETO ApS.
As of September 13, 2014, Geert W Nygaard has joined the board of directors of CHRETO ApS.
As of September 13, 2014, Geert W Nygaard has left the board of directors of CHRETO ApS.
About CHRETO ApS
CHRETO ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kyhse-Andersen. The company's owners include NOVOZYMES A/S, SKEIKAMPEN INVEST ApS and JAN KYHSE-ANDERSEN HOLDING ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK -2,662,874 and a net result of DKK -3,119,901 compared with DKK -2,336,562 the year before. Equity amounted to DKK 49,010,862.
